Filing Deadline Extended
Quick Start for:

NOTE: The products listed are for use by eligible State of Texas entities ONLY and are not for personal purchase or purchase by commercial entities.

Search for Contracts

Enter keywords or NIGP codes to find state contracts:

Contract Details

Contract 269-M1 Vaccines and Biologicals

Start date: 04/2013

End date: 12/2014

  1. DESCRIPTION OF CONTRACT: TPASS MANAGED CONTRACT NO. 269-M1
    Vaccines and Biologicals
  2. HOW TO ORDER: Customers must issue an internal purchase order and reference CPA Contract No. 269-M1 to be eligible for Contract pricing. To avoid order placement delays, also reference customer's account number with the Contractor.

    For State Agencies: Use Purchase Category Code C

    NIGP Class/Item:
    269-36
    269-80

    The Contractor agrees not to ship any materials until issuance of a Purchase Order by the State Agency, Higher Education or Cooperative member.

    New Accounts: If placing an order for the first time with a Contractor, contact the Contractor first and establish an account; ensure contract 269-M1 is referenced.

  3. CONTRACT PRICING AND DELIVERY INFORMATION (XLS)
  4. CONTRACTORS

    Payee ID No.: 15710146349
    BDI Pharma, Inc.
    120 Research Drive
    Columbia SC 29203
    Contact: Hugh McLaurin
    Phone: (800) 948-9834
    Email: hmclaurin@bdipharma.com
    Email for Purchase Orders: bdcontracting@bdipharma.com
    Customer Service for purchase orders: Julianna Bolton
    Phone: (800) 948-9834

    Payee ID No.: 12056388270
    Crucell Vaccines, Inc.
    14210 NW 60th Avenue
    Miami Lakes FL 33014
    Contact: Tibor Koncz
    Phone: (786) 313-8200 ext. 8203
    Email: tkoncz@its.jnj.com
    Customer Service for purchase orders: Lourdes Fandino
    Phone: (786) 313-8200 ext. 8204

    Payee ID No.: 12310990507
    GlaxoSmithKline, LLC
    Three Franklin Plaza, 3F0605
    1600 Vine Street
    Philadelphia PA 19101
    Contact: Babatunde Adedeji
    Phone: (215) 751-6786
    Email: babatunde.a.adedeji@gsk.com
    Email for Purchase Orders: vaccine.service-center@gsk.com
    Customer Service for purchase orders: Matt Hellwarth
    Phone: (215) 751-7887

    Payee ID No.: 19427546247
    Novartis Vaccines & Diagnostics
    One Health Plaza, Bld 431, 5th Floor
    East Hanover NJ 07936
    Contact: Del Negron
    Phone: (512) 574-2808
    Email: patricio.alveal@novartis.com
    Email for Purchase Order: delis.negron@novartis.com

    Payee ID No.: 14316100636
    Regimed Medical
    106 Arabian Path
    St. Peters MO 63376
    Contact: Reginald Maclin
    Phone: (636) 240-1515
    Email: rmaclin@regimedmedical.com

    Payee ID No.: 19800330136
    Sanofi Pasteur Inc.
    Discovery Drive
    Swiftwater PA 78370
    Contact: Jill Bingham
    Phone: (570) 957-3486
    Email: jill.bingham@sanofipasteur.com
    Email for Purchase Order: oprorders@sanofipasteur.com
    Customer Service for purchase orders: (800) 822-2463
    Expedited Payment Discount: 2% in 30 Days

  5. TERM OF CONTRACT: 04/03/2013 through 12/31/2013

    Renewal Term: January 1, 2014 - December 31, 2014

    RENEWAL OPTIONS:
    2nd Renewal Option: January 1, 2015 – December 31, 2015
    3rd Renewal Option: January 1, 2016 – December 31, 2016
    4th Renewal Option: January 1, 2017 – December 31, 2017

  6. INTENDED USE – NOT FOR RESALE: All pharmaceuticals are intended for medicinal use only and will not be used for experimental and/or laboratory procedures.

    All pharmaceuticals will be dispensed in accordance with the pricing guidelines under the Robinson-Patman Price Discrimination Act and Abbott Laboratories v. Portland Retail Druggists Ass'n. Inc, 425 U.S. 1 (1976).

    Product sold under any resultant contract to the State of Texas shall be for the Customer's "own use" and shall not be subject to resale. Customer hereby certifies and represents to Contractor that it is a non-profit institution purchasing the products described herein for its own use as defined in Abbott Laboratories v. Portland Retail Druggists Ass'n. Inc, 425 U.S. 1 (1976) and that the products are not for dispensation to person who are not patients physicians or employees of the customer or for other nonexempt dispensation. Customer further certifies that, in the event of any nonexempt use of these products, customer will submit to Contractor an accounting of such use, to be followed by an appropriate price adjustment. Additionally, violations of this policy, if proven, shall be treated as a breach of the Agreement of sales between an individual member or authorized customer and contractor(s).

    In the event the Contractor identifies a misuse of this contract, they have a right to require an appropriate price adjustment.

    Should Customer charge the end user a fee to administer the product, such administrative fee will not constitute a "resale" for purposes of this provision.

  7. DATE OF EXPIRATION AND ORIGINATION (MANUFACTURER): The vaccine supplied shall not expire or be rendered unusable within twelve (12) months of receipt. The CPA reserves the right to waive this requirement on an individual basis because of the nature or availability of the product.
  8. WARRANTY: Manufacturer's standard warranty applies.
  9. SUBSTITUTIONS: During the Contract term, the Contractor shall not substitute a product or brand unless the Contractor has obtained prior written approval from the CPA Contract Manager in coordination with the Customer. The Contractor must have written confirmation from the CPA Contract Manager of the substitution before making delivery.
  10. CPA CONTRACT MANAGEMENT: Questions regarding contract management issues, price changes, amendments or other post-award concerns should be directed to:

    TPASS Contract Management Office (TCMO)
    Texas Comptroller of Public Accounts (CPA)
    Fax: (512) 936-0040
    tpass_cmo@cpa.state.tx.us

  11. CONTRACTOR PERFORMANCE: The Comptroller of Public Accounts (CPA) administers a vendor performance program for use by all ordering entities per Texas Government Code, Title 10, Subtitle D, Section 2155.077. The Vendor Performance and Debarment Program relies on the ordering entity's participation in gathering information on vendor performance. Ordering Entities shall report vendor performance on purchases over $25,000 from contracts administered by the commission or any other purchase over $25,000 made through delegated authority granted by CPA (TAC 20.108). Agencies are additionally encouraged to report vendor performance on purchases under $25,000.

    Vendor Performance shall be reported through the CPA Vendor Performance Tracking System. The purpose of the system is to:

    • Identify vendors that have exceptional performance.
    • Aid purchasers in making a best value determination based on vendor past performance.
    • Protect the state from vendors with unethical business practices.
    • Provide performance scores in four measurable categories for the CMBL vendors.
    • Track vendor performance for delegated and exempt purchases.
Required Plug-ins